Beijing Science Sun Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 869.906 million compared to CNY 484.520 million a year ago. Operating income was CNY 94.572 million compared to CNY 94.724 million a year ago. Net income was CNY 85.333 million compared to CNY 84.884 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.18 a year ago.